Pulse Biosciences, Inc. provided preliminary earnings Guidance for the three months ended June 30, 2024. For the period, the company expects GAAP net loss in the range of $10.7 million to $12.7 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.05 USD | -2.36% |
|
+30.66% | +57.35% |
07-15 | Pulse Biosciences Enters $60 Million Equity Distribution Agreement | MT |
07-15 | Pulse Biosciences, Inc. Provides Preliminary Earnings Guidance for the Three Months Ended June 30, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+57.35% | 1.19B | |
+3.77% | 208B | |
+7.83% | 182B | |
+29.24% | 155B | |
+35.31% | 115B | |
+2.81% | 66.52B | |
+15.15% | 53.93B | |
-6.47% | 46.26B | |
-3.59% | 38.22B | |
+6.35% | 36.6B |
- Stock Market
- Equities
- PLSE Stock
- News Pulse Biosciences, Inc.
- Pulse Biosciences, Inc. Provides Preliminary Earnings Guidance for the Three Months Ended June 30, 2024